CPT modulates miR-574-5p expression via promoter methylation and targets protein tyrosine phosphatase receptor type U (PTPRU) to influence TLR9 signaling, thereby affecting apoptosis and improving lung cancer [41,42]. The gene discussed is PTPRU; the disease is lung carcinoma.